Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Harris

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antiviral Therapy|May 12, 2009
Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patientsJoshua M Waters, Wesley O'Neal, Kirsten L White, et al.
AIDS (London, England)|September 27, 2005
Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patientsMelanie A Thompson, Harold A Kessler, Joseph J Eron, et al.
The Journal of Infectious Diseases|November 26, 2003
Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patientsFranck S Rousseau, Charles Wakeford, Herve Mommeja-Marin, et al.
Pediatrics|March 12, 2008
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjectsXavier Saez-Llorens, Avy Violari, Dalubuhle Ndiweni, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antiviral Therapy|May 12, 2009
Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patientsJoshua M Waters, Wesley O'Neal, Kirsten L White, et al.
AIDS (London, England)|September 27, 2005
Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patientsMelanie A Thompson, Harold A Kessler, Joseph J Eron, et al.
The Journal of Infectious Diseases|November 26, 2003
Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patientsFranck S Rousseau, Charles Wakeford, Herve Mommeja-Marin, et al.
Pediatrics|March 12, 2008
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjectsXavier Saez-Llorens, Avy Violari, Dalubuhle Ndiweni, et al.
Pageof 2